Literature DB >> 31598598

Pulmonary Function, Aerobic Capacity and Related Variables in Patients With Ankylosing Spondylitis.

Ayla Çağliyan Türk1, Sertaç Arslan2, Yusuf Karavelioğlu3, Macit Kalcik3, Sumru Özel1, Ahmet Musmul4, Füsun Şahin5.   

Abstract

Objectives: This study aims to evaluate the cardiopulmonary functions and exercise performance of patients with ankylosing spondylitis (AS) and to investigate the relationship between these parameters and disease activity, spine mobility and quality of life (QoL). Patients and methods: Forty-five patients with AS (group 1; 33 males, 12 females; mean age 43.1±12.1 years; range 22 to 70 years) and 30 control subjects (group 2; 23 males, 7 females; mean age 42.8±10.0; range 23 to 70 years) were included in the study. Disease activity was assessed with the Bath Ankylosing Spondylitis Disease Activity Index and spinal mobility measures with the Bath Ankylosing Spondylitis Metrology Index (BASMI). The Ankylosing Spondylitis Quality of Life (ASQoL) Questionnaire and the Maastricht Ankylosing Spondylitis Enthesitis Score (MASES) were used. The pulmonary function test (PFT) and cardiopulmonary exercise testing (CPET) were performed.
Results: There was no significant difference between groups 1 and 2 in terms of mean age. The peak expiratory flow value in PFT was significantly lower in group 1 (p<0.05). In group 1, the duration of CPET was significantly shorter, and maximum work load and metabolic equivalent were significantly lower than in group 2 (p<0.001). Maximum oxygen uptake (VO2max) in peak responses, work and heart rate were significantly lower in group 1. The duration of CPET and maximum work were negatively correlated with age and BASMI (p<0.001). VO2max was negatively correlated with age, MASES and ASQoL (p<0.05).
Conclusion: There was no significant difference in PFT parameters between the groups. On the other hand, CPET parameters were significantly lower in the AS group. While CPET parameters are affected by spinal mobility, declining aerobic capacity affects QoL.
Copyright © 2019, Turkish League Against Rheumatism.

Entities:  

Keywords:  Ankylosing spondylitis; cardiopulmonary exercise testing; pulmonary function test; quality of life

Year:  2019        PMID: 31598598      PMCID: PMC6768782          DOI: 10.5606/ArchRheumatol.2019.7145

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  32 in total

1.  Respiratory muscle performance as a possible determinant of exercise capacity in patients with ankylosing spondylitis.

Authors:  Martin van der Esch; Alex J van 't Hul; Monique Heijmans; Joost Dekker
Journal:  Aust J Physiother       Date:  2004

2.  Relation between chest expansion, pulmonary function, and exercise tolerance in patients with ankylosing spondylitis.

Authors:  L R Fisher; M I Cawley; S T Holgate
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

Review 3.  Cardiovascular risks in spondyloarthritides.

Authors:  Sylvia Heeneman; Mat J A P Daemen
Journal:  Curr Opin Rheumatol       Date:  2007-07       Impact factor: 5.006

4.  Aerobic capacity and its correlates in patients with ankylosing spondylitis.

Authors:  Lin-Fen Hsieh; James Cheng-Chung Wei; Hsin-Yi Lee; Chih-Cheng Chuang; Jiunn-Song Jiang; Kae-Chwen Chang
Journal:  Int J Rheum Dis       Date:  2014-04-23       Impact factor: 2.454

5.  An investigation of factors limiting aerobic capacity in patients with ankylosing spondylitis.

Authors:  R Carter; P Riantawan; S W Banham; R D Sturrock
Journal:  Respir Med       Date:  1999-10       Impact factor: 3.415

6.  Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.

Authors:  T R Jenkinson; P A Mallorie; H C Whitelock; L G Kennedy; S L Garrett; A Calin
Journal:  J Rheumatol       Date:  1994-09       Impact factor: 4.666

7.  Exercise performance of subjects with ankylosing spondylitis and limited chest expansion.

Authors:  C G Elliott; T R Hill; T E Adams; R O Crapo; R M Nietrzeba; R M Gardner
Journal:  Bull Eur Physiopathol Respir       Date:  1985 Jul-Aug

8.  A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

Authors:  S Garrett; T Jenkinson; L G Kennedy; H Whitelock; P Gaisford; A Calin
Journal:  J Rheumatol       Date:  1994-12       Impact factor: 4.666

Review 9.  Ankylosing spondylitis.

Authors:  Jürgen Braun; Joachim Sieper
Journal:  Lancet       Date:  2007-04-21       Impact factor: 79.321

10.  Assessment of enthesitis in ankylosing spondylitis.

Authors:  L Heuft-Dorenbosch; A Spoorenberg; A van Tubergen; R Landewé; H van ver Tempel; H Mielants; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-02       Impact factor: 19.103

View more
  1 in total

1.  Evaluation of the Swallowing and Voice Functions in Ankylosing Spondylitis Patients.

Authors:  Esmail Abdulahi Ahmed; Sevgi Atar; Yavuz Atar; Hüseyin Sari; Melis Ece Arkan Anarat; Ziya Saltürk; Seyma Görcin Karaketir; Yavuz Uyar; Ömer Kuru
Journal:  Dysphagia       Date:  2021-07-14       Impact factor: 3.438

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.